Literature DB >> 4541250

[Differentiating behavior of eyelid basaliomas and of their surroundings].

H Meythaler.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4541250     DOI: 10.1007/bf00411210

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


× No keyword cloud information.
  33 in total

1.  [The roentgenotherapy of cancers of the eyelids].

Authors:  F BACLESSE; M A DOLLFUS
Journal:  Arch Ophtalmol Rev Gen Ophtalmol       Date:  1960 Jul-Aug

2.  [The treatment of malignant tumors of the eyelids and their adjacent areas].

Authors:  R THIEL
Journal:  Klin Monbl Augenheilkd       Date:  1963-02       Impact factor: 0.700

3.  [Contribution to the clinical and therapeutic study of eyelid cancer].

Authors:  P VANCEA; G CHISLEAG
Journal:  Klin Monbl Augenheilkd       Date:  1963-07       Impact factor: 0.700

4.  [Results of close range irradiation of eyelid carcinoma].

Authors:  W MOLDENHAUER
Journal:  Klin Monbl Augenheilkd Augenarztl Fortbild       Date:  1958

5.  [Malignant tumors of the eyelids].

Authors:  C E GARCIGA
Journal:  Arch Cuba Cancerol       Date:  1955 Oct-Dec

6.  Correlation of rate of growth with histologic characteristics of basal cell carcinoma.

Authors:  H A TELOH
Journal:  AMA Arch Derm Syphilol       Date:  1953-10

7.  Carcinoma of the eyelid; analysis of 301 cases and review of the literature.

Authors:  C G STETSON; M D SCHULZ
Journal:  N Engl J Med       Date:  1949-11-10       Impact factor: 91.245

8.  [Symptoms and histology of sebaceous neva and carcinomata; their relation to the so-called basal cell carcinoma].

Authors:  W NIKOLOWSKI
Journal:  Arch Dermatol Syph       Date:  1951-11

9.  Reappraisal of basal cell carcinoma of the eyelids.

Authors:  A L Aurora; F C Blodi
Journal:  Am J Ophthalmol       Date:  1970-09       Impact factor: 5.258

10.  [Familial basalioma].

Authors:  A Nover
Journal:  Klin Monbl Augenheilkd       Date:  1970-10       Impact factor: 0.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.